|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
0.94/1.21
|
企业价值
2.48B
|
资产负债 |
每股账面净值
4.88
|
现金流量 |
现金流量率
0.05
|
损益表 |
收益
482.38M
|
每股收益
4.33
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/03 02:49 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. |